Back

Systems level analysis of B-cell development identifies BDNF as a driver for human B lymphopoiesis

Nevo, N.; Klein, Y.; Alpert, A.; Grau, A.; Melamed, D.; Milman, N.; Few-Cooper, T. J.; Shen-Orr, S. S.

2025-09-04 systems biology
10.1101/2025.08.29.673055 bioRxiv
Show abstract

B-cell aplasia impairs the immune response to cancer, infections and vaccines. However, no B-cell accelerator is available in the clinic to date. Here, we utilized a system biology approach to discover drivers for B lymphopoiesis in the human Bone Marrow (BM). By integrating scRNA-seq data analyses with intercellular communication mapping, we created an initial list of putative drivers emanating from the BM microenvironment and interacting with nascent B lymphocytes. We further intersected our findings with clinical B-cell depletion studies and developmental conditions pointing at age-impaired B lymphopoiesis. These funneling procedures enabled identification of putative top drivers on which we performed progenitor BM cells scRNA-seq stimulation assays, demonstrating their ability to upregulate immune developmental pathways within early B-cells. Finally, we succesfully validated BDNF, a neurotrophin, as a B-cell accelerator in in-vitro culture. Our systems-biology methodology paves the way towards identification of additional human hematopoiesis drivers and immune recovery and functionality.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.